Sphenopalatine Ganglion Blocks RCT

• Status: Completed
• Trial end date: 2021-07-08
• Target enrollment: 0
• Participant gender: All

Summary

RCT of Sphenopalatine Ganglion (SPG) Blocks using anesthetics vs. placebo for migraine.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of California, San Francisco
• Treatments: Bupivacaine; Lidocaine; Ropivacaine

Criteria

Inclusion Criteria:

1. Age 18 years or more at time of consent

2. Current patients in the UCSF Headache Center eligible to receive SPG blocks for migraine and would otherwise receive treatment clinically

3. Ability to provide consent for the research study

Exclusion Criteria

1. Pregnant or breast feeding within 4 weeks of enrollment

2. Inability to communicate with the study team

3. Patients who cannot read and understand English

4. Deemed unsuitable for enrollment in study by the investigator

5. Allergy to local anesthetics or saline